Advertising Disclaimer
Published online October 31, 2008
PEDIATRICS Vol. 122 No. 5 November 2008, pp. 1064-1071 (doi:10.1542/peds.2007-3770)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montini, G.
Related Collections
Right arrow Genitourinary Tract
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Prophylaxis After First Febrile Urinary Tract Infection in Children? A Multicenter, Randomized, Controlled, Noninferiority Trial

Giovanni Montini, MDa, Luca Rigon, MDa, Pietro Zucchetta, MDb, Federica Fregonese, MDc, Antonella Toffolo, MDd, Daniela Gobber, MDe, Diego Cecchin, MDb, Luigi Pavanello, MDf, Pier Paolo Molinari, MDg, Francesca Maschio, MDh, Sergio Zanchetta, MDi, Walburga Cassar, MDj, Luca Casadio, MDk, Carlo Crivellaro, MDl, Paolo Fortunati, MDm, Andrea Corsini, MDn, Alessandro Calderan, MDo, Stefania Comacchio, MDa, Lisanna Tommasi, MDa, Ian K. Hewitt, MBBSa, Liviana Da Dalt, MDp, Graziella Zacchello, MDa, Roberto Dall'Amico, MD, PhDq on behalf of the IRIS group

Departments of a Pediatric Nephrology
b Nuclear Medicine
c Pediatrics
e Epidemiology Unit
p Pediatric Emergency Department, Azienda Ospedaliera-University of Padua, Italy; Pediatric Unit
d Oderzo
f Castelfranco Veneto
g Bologna
h Mestre-Venezia
i Soave
j Bolzano
k Ravenna
l Piove di Sacco-Chioggia
m Verona-Borgo Trento
n Bentivoglio
q Thiene, Italy
o General Practitioner, San Donà di Piave-Venezia, Italy

OBJECTIVES. Febrile urinary tract infections are common in children and associated with the risk for renal scarring and long-term complications. Antimicrobial prophylaxis has been used to reduce the risk for recurrence. We performed a study to determine whether no prophylaxis is similar to antimicrobial prophylaxis for 12 months in reducing the recurrence of febrile urinary tract infections in children after a first febrile urinary tract infection.

METHODS. The study was a controlled, randomized, open-label, 2-armed, noninferiority trial comparing no prophylaxis with prophylaxis (co-trimoxazole 15 mg/kg per day or co-amoxiclav 15 mg/kg per day) for 12 months. A total of 338 children who were aged 2 months to <7 years and had a first episode of febrile urinary tract infection were enrolled: 309 with a confirmed pyelonephritis on a technetium 99m dimercaptosuccinic acid scan with or without reflux and 27 with a clinical pyelonephritis and reflux. The primary end point was recurrence rate of febrile urinary tract infections during 12 months. Secondary end point was the rate of renal scarring produced by recurrent urinary tract infections on technetium 99m dimercaptosuccinic acid scan after 12 months.

RESULTS. Intention-to-treat analysis showed no significant differences in the primary outcome between no prophylaxis and prophylaxis: 12 (9.45%) of 127 vs 15 (7.11%) of 211. In the subgroup of children with reflux, the recurrence of febrile urinary tract infections was 9 (19.6%) of 46 on no prophylaxis and 10 (12.1%) of 82 on prophylaxis. No significant difference was found in the secondary outcome: 2 (1.9%) of 108 on no prophylaxis versus 2 (1.1%) of 187 on prophylaxis. Bivariate analysis and Cox proportional hazard model showed that grade III reflux was a risk factor for recurrent febrile urinary tract infections. Whereas increasing age was protective, use of no prophylaxis was not a risk factor.

CONCLUSIONS. For children with or without primary nonsevere reflux, prophylaxis does not reduce the rate of recurrent febrile urinary tract infections after the first episode.


Key Words: urinary tract infection • antibiotic prophylaxis • renal scar • DMSA scan

Abbreviations: UTI—urinary tract infection • RR—relative risk • CI—confidence interval • VUR—vesicoureteral reflux • ITT—intention-to-treat • DMSA—dimercaptosuccinic acid • VCUG—voiding cystourethrography • IQR—interquartile range


Accepted Mar 3, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
J. C. Craig, J. M. Simpson, G. J. Williams, A. Lowe, G. J. Reynolds, S. J. McTaggart, E. M. Hodson, J. R. Carapetis, N. E. Cranswick, G. Smith, et al.
Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children
N. Engl. J. Med., October 29, 2009; 361(18): 1748 - 1759.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Hoberman and R. Keren
Antimicrobial Prophylaxis for Urinary Tract Infection in Children
N. Engl. J. Med., October 29, 2009; 361(18): 1804 - 1806.
[Full Text] [PDF]


Home page
Therapeutic Advances in UrologyHome page
G. Lackgren and A. Stenberg
Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment
Therapeutic Advances in Urology, August 1, 2009; 1(3): 131 - 141.
[Abstract] [PDF]


Home page
Arch. Dis. Child.Home page
H. Bauchner
Atoms
Arch. Dis. Child., April 1, 2009; 94(4): i - i.
[Full Text] [PDF]


Home page
AAP Grand RoundsHome page
M. H. Rathore
Prophylaxis After First UTI May Not Be Necessary
AAP Grand Rounds, March 1, 2009; 21(3): 26 - 26.
[Full Text] [PDF]


Home page
PediatricsHome page
I. K. Hewitt and G. Montini
Treatment of Pyelonephritis and Risk of Renal Scarring: In Reply
Pediatrics, March 1, 2009; 123(3): e545 - e545.
[Full Text] [PDF]


Home page
PediatricsHome page
G. Montini, P. Zucchetta, L. Tomasi, E. Talenti, W. Rigamonti, G. Picco, A. Ballan, A. Zucchini, L. Serra, V. Canella, et al.
Value of Imaging Studies After a First Febrile Urinary Tract Infection in Young Children: Data From Italian Renal Infection Study 1
Pediatrics, February 1, 2009; 123(2): e239 - e246.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. Travan, M. Pennesi, and L. Ronfani
Is Antibiotic Prophylaxis in Children With Vesicoureteral Reflux Effective in Preventing Pyelonephritis and Renal Scars? A Randomized, Controlled Trial: In Reply
Pediatrics, December 1, 2008; 122(6): 1410 - 1411.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Does Antibiotic Prophylaxis Prevent UTI Recurrence in Children?
Journal Watch (General), November 13, 2008; 2008(1113): 7 - 7.
[Full Text]